RFK Jr.'s HHS lets 6 unapproved peptides sell
RFK Jr.'s HHS lets 6 unapproved peptides sell
RFK Jr.'s HHS lets 6 unapproved peptides sell
Key points
اہم نکات
मुख्य बातें
- The US Department of Health and Human Services will not take enforcement action against licensed compounding pharmacies that make and sell six unapproved peptides, under a draft policy signed by Health Secretary Robert F.
- Kennedy Jr., Forbes reports.
- The six — BPC-157, TB-500, KPV, MOTS-c, Semax and Epitalon — can be compounded for patients with a prescription, but none of them is FDA-approved.
- The US Department of Health and Human Services will not take enforcement action against licensed compounding pharmacies that make and sell six unapproved peptides, under a draft policy signed by Health Secretary Robert F.
- Kennedy Jr., Forbes reports.
- The six — BPC-157, TB-500, KPV, MOTS-c, Semax and Epitalon — can be compounded for patients with a prescription, but none of them is FDA-approved.
- The US Department of Health and Human Services will not take enforcement action against licensed compounding pharmacies that make and sell six unapproved peptides, under a draft policy signed by Health Secretary Robert F.
- Kennedy Jr., Forbes reports.
- The six — BPC-157, TB-500, KPV, MOTS-c, Semax and Epitalon — can be compounded for patients with a prescription, but none of them is FDA-approved.
The US Department of Health and Human Services will not take enforcement action against licensed compounding pharmacies that make and sell six unapproved peptides, under a draft policy signed by Health Secretary Robert F. Kennedy Jr., Forbes reports. The six — BPC-157, TB-500, KPV, MOTS-c, Semax and Epitalon — can be compounded for patients with a prescription, but none of them is FDA-approved. The policy, published in the Federal Register on October 30, is only an interim enforcement-discretion step, and FDA scientists largely oppose it, saying there is too little evidence about safety and effectiveness. Kennedy has called himself a big fan of peptides and says he has used BPC-157 for a muscle injury. The public can comment on the draft until November 13.
The US Department of Health and Human Services will not take enforcement action against licensed compounding pharmacies that make and sell six unapproved peptides, under a draft policy signed by Health Secretary Robert F. Kennedy Jr., Forbes reports. The six — BPC-157, TB-500, KPV, MOTS-c, Semax and Epitalon — can be compounded for patients with a prescription, but none of them is FDA-approved. The policy, published in the Federal Register on October 30, is only an interim enforcement-discretion step, and FDA scientists largely oppose it, saying there is too little evidence about safety and effectiveness. Kennedy has called himself a big fan of peptides and says he has used BPC-157 for a muscle injury. The public can comment on the draft until November 13.
The US Department of Health and Human Services will not take enforcement action against licensed compounding pharmacies that make and sell six unapproved peptides, under a draft policy signed by Health Secretary Robert F. Kennedy Jr., Forbes reports. The six — BPC-157, TB-500, KPV, MOTS-c, Semax and Epitalon — can be compounded for patients with a prescription, but none of them is FDA-approved. The policy, published in the Federal Register on October 30, is only an interim enforcement-discretion step, and FDA scientists largely oppose it, saying there is too little evidence about safety and effectiveness. Kennedy has called himself a big fan of peptides and says he has used BPC-157 for a muscle injury. The public can comment on the draft until November 13.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।